Correlation Between Caribou Biosciences and Codexis

Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Codexis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Codexis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Caribou Biosciences and Codexis, you can compare the effects of market volatilities on Caribou Biosciences and Codexis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Codexis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Codexis.

Diversification Opportunities for Caribou Biosciences and Codexis

0.92

Correlation Coefficient

Caribou Biosciences  Codexis

Almost no diversification

The 3 months correlation between Caribou and Codexis is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Codexis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codexis and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Codexis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codexis has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Codexis go up and down completely randomly.

Pair Corralation between Caribou Biosciences and Codexis

Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Codexis. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 1.3 times less risky than Codexis. The stock trades about -0.18 of its potential returns per unit of risk. The Codexis is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest  467.00  in Codexis on December 29, 2024 and sell it today you would lose (175.00) from holding Codexis or give up 37.47% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Caribou Biosciences  vs.  Codexis

Caribou Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Codexis

Risk-Adjusted Performance

Very Weak

Over the last 90 days Codexis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Caribou Biosciences and Codexis

The main advantage of trading using opposite Caribou Biosciences and Codexis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Codexis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codexis will offset losses from the drop in Codexis' long position.

The idea behind Caribou Biosciences and Codexis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.